Review decison: May 2012
Review of NICE Technology Appraisal Guidance 170: Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults
The Institute was proposing that the guidance be transferred to the ‘static guidance list’.
During consultation, the majority of comments received by the Institute agreed with the proposal put forward. After consideration of all of the comments (attached as appendix A), the Institute’s Guidance Executive has decided to proceed with the proposal. The guidance will now be transferred to the list of static appraisals.
This page was last updated: 22 May 2012